Brief: NewAmsterdam Pharma Company NV Files For Mixed Shelf Of Up To $500 Million - SEC Filing
Feb 28 (Reuters) - NewAmsterdam Pharma Company NV KH6.F: NEWAMSTERDAM PHARMA COMPANY NV FILES FOR MIXED SHELF OF UP TO $500 MILLION - SEC FILING Source text: [ID:n0001193125-25-042775] Further company coverage: KH6.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewAmsterdam Pharma
See all newsBrief: Menarini Group & Newamsterdam Pharma Receive European Commission Approval For Ubeslo And Evlarco
Amgen falls after Novartis trial setback, BMO downgrade
Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Newamsterdam Pharma Company N.V. - Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
Brief: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)